Theme: Advancements and Breakthroughs in the Fields of Dementia Research and Development
We welcome all the participants from all over the world to attend ‘ 17th International Conference on Dementia and Alzheimer Disease is scheduled on July 18-19, 2022 Amsterdam, Netherlands which will be through on stream and participants like keynote, special sessions, poster, oral presentations will deliver their talk on-stream.
Can we cure Dementia?
Discovering the friend or family member has Alzheimer's or other types of dementia is Scary. One of the primary inquiry is individuals inquires as to whether there is a cure or an approach to recouping? Not all loss of memory is recognized with Alzheimer's or dementia. There are different reasons you may encounter memory issues including thyroid issues, stretch and vitamin insufficiencies or certain medicines.
There is currently no "cure" for dementia. Dementia is triggered by different diseases that are why it is impossible that there will be a solitary cure for dementia.
Dementia, as well as Alzheimer’s disease, is one of the biggest global public health challenges facing our generation. Worldwide, at least 44 million people are living with insanity this range is anticipated to double by 2030 and quite triple by 2050 to 115 million. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of individuals with Dementia board developing countries. Today, over 35 million individuals worldwide presently abide the condition. No medicines out there to slow or stop the cerebrum damage brought about by Alzheimer's malady, a few prescriptions can briefly help improve the side effects of dementia for certain individuals. In 20 Years, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.
Why to attend???
Dementia - 2022 will provide an opportunity for all stakeholders working on Alzheimer’s disease and Dementia to talk about novel research. Dementia Online event can assemble notable speakers, neurologist’s and Dementia researchers from both academia and health care industry will join together to discuss their views and research. The conference will be comprised of sessions by world category specialists in the field of neurology. In dementia on-stream meet 2022, international symposiums, B2B conferences, international workshops will be organized to debate the particular topics within the field of dementia and Alzheimer’s disease.
Track 3: Parkinson Diseases
Track 6: Dementia Nursing
Track 10:Alzheimer’s disease Pathogenesis
Track 12 : Diagnostic Alzheimer’s & Novel Therapeutics
Track 15: Alzheimer’s Disease and Type 2 Diabetes
Track 16: Memory Disorders & Neurologic problems
Track 18: Amyloid protein in Dementia
It is formed from the breakdown of a larger protein, called amyloid precursor protein. One form, beta-amyloid 42, is thought to be especially toxic. In the Alzheimer's brain, abnormal levels of this naturally occurring protein clump together to form plaques that collect between neurons and disrupt cell function.Hereditary cerebral amyloid angiopathy is a condition that can cause a progressive loss of intellectual function (dementia), stroke, and other neurological problems starting in mid-adulthood. Alzheimer's disease is thought to be caused by the abnormal build-up of 2 proteins called amyloid and tau. Deposits of amyloid, called plaques, build up around brain cells. Deposits of tau form "tangles" within brain cells.Whitefoods,including pasta, cakes, white sugar, white rice and white bread. Consuming these causes a spike in insulin production and sends toxins to the brain. Microwave popcorn contains diacetyl, a chemical that may increase amyloid plaques in the brain.
Track:19 Ageing & Dementia
While some mild changes in cognition are considered a normal part of the aging process, dementia is not. Normal age-related declines are subtle and mostly affect the speed of thinking and intentional control. Although dementia is not an unavoidable consequence of ageing, increasing age is the biggest risk factor for having this disease. The prevalence of dementia increases exponentially with age and 95% of those with Alzheimer's disease, the most common form of dementia, are aged 65 or over.
Ageing is a risk factor for dementia because dementia can take a long time to develop. This is because dementia is caused by diseases that damage the brain, such as Alzheimer's disease or vascular disease. It can take these diseases many years to damage the brain enough to cause the symptoms of dementia.
Track 20: Neuroimaging Biomarker
These biomarkers are quantifiable characteristics of biological processes related to Alzheimer's disease that are linked to clinical endpoints and thus can be used as surrogates for the disease process. Over the last decade, numerous advances have been made in developing biomarkers for AD using neuroimaging approaches. Neuroimaging is a branch of medical imaging that focuses on the brain. In addition to diagnosing disease and assessing brain health, neuroimaging also studies: How the brain works. How various activities impact the brain.
Blood, urine, and cerebrospinal fluid provide the necessary biological information for the diagnosis. In these conditions, biomarkers are used as an indicator of a biological factor that represents either a subclinical manifestation, stage of the disorder, or a surrogate manifestation of the disease.
Track: 21: Interstitial lung disease
Brain is the most complicated and sensitive organ inside the body. Minute damages to the mind might purpose devastating results main to several mind disorders. It may arise in early life causing developmental disorders together with autism,dyslexiaPsychiatricdiseases inclusiveof melancholy and schizophrenia are generally identified in teenagers or early maturity and as we age we emerge as increasingly vulnerable to Alzheimer’s ailment, Parkinson’s disorder, stroke, and other diseases. This session encourages a discussion on the structural and functional elements of the brain. There are 10 million individuals in the UK residing with a neurological circumstance which significantly impacts their lives. Basically, stroke, dementia, cerebral pain, Brain damage and epilepsy are the neurological conditions endured in the UK. It has been evaluated that the lifetime danger of growing Brain and different neural sensory device disease is 1 of every 133 for guys and 1 of each 185 for girls within the UK.
Dementia is a general term that describes a group of symptoms-such as decline in mental capability, judgment, language, complex motor skills, and other intellectual function-caused by brain damage from cerebrovascular, death of the brain's nerve cells, or neurons. Dementia may be caused by a number of factors, such as drug abuse, alcoholism, brain injury, side effects to certain medications, thyroid function abnormalities, vitamin B12 deficiency, etc.
Dementia including Alzheimer’s disease, is one of the biggest global public health challenges and disorder facing our generation. Vascular dementia is the second most common cause of dementia caused by brain damage.
From recent reports, markets for Alzheimer’s treatments exist with the development of some therapeutic methods and the increasing incidence of the disease. The increasing incidence of Alzheimer’s disease is mainly attributed to the growing number of people over the age of 65. Although some instances of young-onset have occurred, this is defined as Alzheimer’s symptoms in people under the age of 65. Alzheimer’s disease is estimated to affect up to 6% of the population over 65.
- Interstitial Lung Disease
- Dementia Care Management
- Parkinson Diseases
- Vascular Dementia
- Childhood Trauma and Dementia
- Dementia Nursing
- Geriatrics Dementia and Alzheimerâ€™s Disease
- Clinical features and Physiotherapy for dementia
- Neurological Diseases
- Alzheimerâ€™s Disease Parthenogenesis
- Alzheimerâ€™s Diseases
- Diagnostic Alzheimerâ€™s & Novel Therapeutics
- Alzheimerâ€™s Clinical Trials and Studies
- Alzheimer Disease and Cellular Mechanisms
- Alzheimerâ€™s Disease and Type 2 Diabetes
- Memory Disorders & Neurologic problems
- Medical Biotechnology and Alzheimerâ€™s Disease
- Amyloid Protein in Dementia
- Ageing & Dementia
- Neuroimaging Biomarker
To share your views and research, please click here to register for the Conference.